INDHIRA PIQUION: Open Payments
NPI 1477048551 · SUNRISE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 13 payments from 9 companies in 2025. Trend: 2023 $192 · 2024 $508 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Hologic Sales and Service, LLC | 1 | $36 |
| Janssen Biotech, Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Optinose US, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: REZDIFFRA, JARDIANCE, APTIMA, TREMFYA, Kerendia, Xhance, Dexcom G6 Transmitter, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
